COLOPLAST SP.ADR 1/10 DK1 Market Cap ($12.73 Billion)
Market Cap & Net Worth: COLOPLAST SP.ADR 1/10 DK1 (CBH)
COLOPLAST SP.ADR 1/10 DK1 market cap. COLOPLAST SP.ADR 1/10 DK1 (F:CBH) has a market capitalization of $12.73 Billion (€10.89 Billion) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #1790 globally and #387 in its home market, demonstrating a -2.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying COLOPLAST SP.ADR 1/10 DK1's stock price €5.50 by its total outstanding shares 2073667960 (2.07 Billion). Also see COLOPLAST SP.ADR 1/10 DK1 (CBH) cash flow conversion for how efficiently the company converts equity into cash flow.
COLOPLAST SP.ADR 1/10 DK1 Market Cap History (2021–2026)
COLOPLAST SP.ADR 1/10 DK1 market cap history from 2021 to 2026. Data shows change from $34.58 Billion to $15.15 Billion (-14.63% CAGR). Check COLOPLAST SP.ADR 1/10 DK1 stock quote for real-time trading data and today's change.
COLOPLAST SP.ADR 1/10 DK1 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how COLOPLAST SP.ADR 1/10 DK1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore COLOPLAST SP.ADR 1/10 DK1 equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.93x
COLOPLAST SP.ADR 1/10 DK1's market cap is 0.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.99x
COLOPLAST SP.ADR 1/10 DK1's market cap is 4.99 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $34.58 Billion | $19.43 Billion | $4.83 Billion | 1.78x | 7.17x |
| 2022 | $25.51 Billion | $22.58 Billion | $4.71 Billion | 1.13x | 5.42x |
| 2023 | $24.57 Billion | $24.50 Billion | $4.78 Billion | 1.00x | 5.14x |
| 2024 | $25.21 Billion | $27.03 Billion | $5.05 Billion | 0.93x | 4.99x |
Competitor Companies of CBH by Market Capitalization
Companies near COLOPLAST SP.ADR 1/10 DK1 in the global market cap rankings as of November 1, 2026. Also see COLOPLAST SP.ADR 1/10 DK1 total assets for a full breakdown of the balance sheet.
Key companies related to COLOPLAST SP.ADR 1/10 DK1 by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.77 Billion USD ( €85.34 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #421 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #536 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $432.01 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.77 Billion | €184.30 |
| #421 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €87.50 |
| #536 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of COLOPLAST SP.ADR 1/10 DK1 (2021–2026)
Market capitalization of COLOPLAST SP.ADR 1/10 DK1 from 2021 to today. Between 2021 and today, COLOPLAST SP.ADR 1/10 DK1's market cap moved from $34.58 Billion to $ 15.15 Billion, with a yearly change of -14.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €15.15 Billion | -16.67% |
| 2025 | €18.18 Billion | -27.88% |
| 2024 | €25.21 Billion | +2.63% |
| 2023 | €24.57 Billion | -3.68% |
| 2022 | €25.51 Billion | -26.25% |
| 2021 | €34.58 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of COLOPLAST SP.ADR 1/10 DK1 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.73 Billion USD |
| MoneyControl | $12.73 Billion USD |
| MarketWatch | $12.73 Billion USD |
| marketcap.company | $12.73 Billion USD |
| Reuters | $12.73 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About COLOPLAST SP.ADR 1/10 DK1
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more